GNAS and glioblastoma: Other possible signatures of recurrent tumour resistance in this GBM cohort included CNV gains in the genes (chromosome), BRCA2 (Chr13), GNAS (Guanine nucleotide-binding protein G(s) subunit alpha; Chr20), and EGFR (Chr7).